Review of synergistic potential between GLP-1 drugs and radiotherapy for brain cancer explores how metabolic peptide therapy could enhance radiation effectiveness.
Key findingReview of synergistic potential between GLP-1 drugs and radiotherapy for brain cancer explores how m
What the researchers found
Review of synergistic potential between GLP-1 drugs and radiotherapy for brain cancer explores how metabolic peptide therapy could enhance radiation effectiveness.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006).
Current radiopharmaceuticals, 18(4), 318-332
Citation
Atasoy, Ozum; Anadol, Elvan; Yar Saglam, Atiye Seda; Akdemir, Eyub Yasar; Coskun, Yasemin Sengun; Atak, Ece; Dincer, Sefika; Usta, Duygu Deniz; Emniyet Sert, Aslı; Kaplanoglu, Gulnur Take; Guney, Yıldız. (2025). Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006).. Current radiopharmaceuticals, 18(4), 318-332. https://doi.org/10.2174/0118744710381356250429045716